Morphotek, Inc.

Morphotek Announces Acceptance of Investigational New Drug Application for MORAb-003, a humanized monoclonal antibody for the treatment of advanced ovarian cancer

Morphotek Announces Acceptance of Investigational New Drug Application for MORAb-003, a humanized monoclonal antibody for the treatment of advanced ovarian cancer

March 28, 2005

Exton, PA, March 28, 2005– Morphotek, Inc. today announced that the United States Food and Drug Administration has accepted its Investigational New Drug (IND) Application for treatment of advanced ovarian cancer with MORAb-003, a humanized monoclonal antibody. The Phase I clinical study is designed as an open label single dose escalation safety study in patients with chemo-refractive ovarian cancer.

Black Duck Software, Inc.

Black Duck Launches protexIP/OnDemand Hosted Service To Analyze Software for Open Source License Compliance

Black Duck Launches protexIP/OnDemand Hosted Service To Analyze Software for Open Source License Compliance

March 28, 2005

Lets Software Developers, Outsourcers, and Due Diligence Teams Meet Compliance Deadlines with Easy-to-Use, Automated Service

Ensemble Therapeutics Corporation

Ensemble Discovery Names Richard F. Begley as CEO; Begley Leverages Knowledge of Chemistry, Biology and Engineering

Ensemble Discovery Names Richard F. Begley as CEO; Begley Leverages Knowledge of Chemistry, Biology and Engineering

April 4, 2005

CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 4, 2005--Ensemble Discovery Corporation, an early stage company developing a revolutionary approach to create new products in life Sciences, materials, and chemicals through its proprietary DNA Programmed Chemistry(TM) platform, has named Richard F. Begley, Ph.D., as president and chief executive officer.

Morphotek, Inc.

Morphotek Announces Multi-Year, Research Collaboration Agreement with Amgen to Optimize Expression of Antibodies

Morphotek Announces Multi-Year, Research Collaboration Agreement with Amgen to Optimize Expression of Antibodies

April 18, 2005

Exton, PA -- April 18, 2005 -- Morphotek Inc. today announced that it has entered into a multi-year Research Collaboration Agreement with Amgen Inc. to apply Morphotek's proprietary MORPHODOMA® technology to Amgen's proprietary cell lines to generate high-titer antibody producing cell lines for scaleable manufacturing.
 

Black Duck Software, Inc.

Black Duck Software Secures $12M in Series B Financing Led by Fidelity Ventures

Black Duck Software Secures $12M in Series B Financing Led by Fidelity Ventures

June 6, 2005

With Participation from Intel, SAP Ventures, and Original Investors Flagship Ventures, General Catalyst Partners, and Red Hat

IntelliVid

IntelliVid Announces Funding

IntelliVid Announces Funding

June 7, 2005

Company Offers Groundbreaking Intelligent Video Analysis Solutions for Retail Loss Prevention

Brainshark, Inc.

Brainshark, Inc. Secures $6.9 Million Financing in Oversubscribed Round

Brainshark, Inc. Secures $6.9 Million Financing in Oversubscribed Round

June 13, 2005

Bullish Outlook For Company's Leadership in Rapidly Growing Segment of Web-based Communications Market Attracts Investment from New and Existing Investors to Fund Expansion

Adnexus Therapeutics

Compound Therapeutics Appoints Dr. John Mendlein as CEO

Compound Therapeutics Appoints Dr. John Mendlein as CEO

June 15, 2005

Biotech executive to accelerate partnering and development of a breakthrough class of pharmaceuticals

Selventa

Genstruct Expands Scientific Advisory Board and Management Team with Industry Experts

Genstruct Expands Scientific Advisory Board and Management Team with Industry Experts

June 20, 2005

CAMBRIDGE, Mass., June 20 /PRNewswire/ -- Genstruct, Inc., a knowledge-driven discovery company using systems biology to discover biomarkers that increase the effectiveness of drug discovery and development, today announced that Alan Williamson, Ph.D. has joined its Scientific Advisory Board (SAB). The company has also appointed Charlie Lieu as director of Business Development and Marketing.

IntelliVid

IntelliVid Announces New Board Member, Board of Advisors

IntelliVid Announces New Board Member, Board of Advisors

June 21, 2005

Intelligent Video Analysis Leader Names Industry Visionary to Board of Directors and Unveils Advisory Board of Industry Leaders

CAMBRIDGE, Mass.--(BUSINESS WIRE)--June 21, 2005--IntelliVid Corporation, the leader in Intelligent Video Analysis solutions for retail loss prevention, today named Domenic J. LaCava to its Board of Directors and unveiled its Advisory Board of senior industry executives.